Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: Effect of antigen form on the induction of cellular and humoral immune responses

Viral Immunology

Volumn 9, Issue 1, 1996, Pages 11-22

  Baca Estrada, M E ^a   Snider, M ^a   Tikoo, S K ^a   Harland, R ^a   Babiuk, L A ^a   Van Drunen Littel Van Den Hurk, S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BOVINE HERPES VIRUS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINE PRODUCTION; VIRUS INFECTION;

ANIMALIA; BOVINAE; BOVINE HERPESVIRUS 1; HERPES; HERPESVIRIDAE; HERPESVIRUS 1;

EID: 0029898645     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.11     Document Type: Article

References (32)

1. Babiuk, L.A., J. L'Italien, S. van Drunen Littel-van den Hurk, T.J. Zamb, M.J.P. Lawman, G. Hughes, and G.A. Gifford. 1987. Protection of cattle from bovine herpesvirus type-1 (BHV-1) infection by immunization with individual glycoproteins. Virology 159:57-66.
2. Babiuk, L.A., R.C. Wardley, and B.T. Rouse. 1975. Defense mechanisms against bovine herpesvirus: Relationship of virus host cell events to susceptibility to antibody-complement lysis. Infect. Immun. 12:958-963.
3. Bretscher, P.A., G. Wei, J.N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Lieshmania major. Science 257:539-542.
4. Collins, P.L., and G. Mottet. 1991. Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity. J. Virol. 65:2362-2371.
5. Cox, J.C., and A.R. Coulter. 1992. Advances in adjuvant technology and application. Pp. 49-111. In W.K. Yong (ed.): Animal parasite control utilizing biotechnology. CRC Press, Boca Raton, FL.
6. Czerkinsky, C., G. Andersson, H.P. Ekre, L.A. Nilsson, L. Klareskog, and O. Ouchterlony. 1988. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110:29-36.
7. Frerichs, G.N., S.B. Woods, M.H. Lucas, and J.J. Sands. 1982. Safety and efficacy of live and inactivated infectious rhinotracheitis vaccines. Vet. Rec. 111:116-122.
8. Gerber, J.D., A.E. Marron, and C.J. Kucera. 1978. Local and systemic cellular and antibody immune responses of cattle to infectious bovine rhinotracheitis virus vaccine administrated intranasally or intramuscularly. Am. J. Vet. Res. 39:753-760.
9. Gibbs, E.P.J., and M.M. Rweyemamu. 1977. Bovine herpesvirus I. Bovine herpesvirus-1. Vet. Bull. (London) 47:317-343.
10. Harland, J.R., A.A. Potter, S. van Drunen-Littel-van den Hurk, J. Van Donkersgoed, M.D. Parker, T.J. Zamb, and E.D. Janzen. 1992. The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Can. Vet. J. 33:734-741.
11. Hopp, T.P. 1984. Immunogenicity of a synthetic HBsAg peptide enhancement by conjugation to fatty acid carrier. Mol. Immunol. 21:13-16.
12. Hughes, G., L.A. Babiuk, and S. van Drunen Littel-van den Hurk. 1988. Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV. Arch. Virol. 103:47-60.
13. Hutchings, D.L., S. van Drunen Littel-van den Hurk, and L.A. Babiuk. 1990. Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle. J. Virol. 64:5114-5122.
14. Hyland, S.J., B.C. Easterday, and R. Pawlisch. 1974. Antibody levels and immunity to infectious bovine rhinotracheitis virus (IBR) infection in Wisconsin dairy cattle. Dev. Biol. Stand. 28:510-525.
15. Jensen, R., R.E. Pierson, P.M. Braddy, D.S. Saari, L.H. Lauerman, J.J. England, H. Keyvanfar, J.R. Collier, D.P. Horton, A.E. McChesney, A. Benitez, and R.M. Christie. 1976. Shipping fever pneumonia in yearling feedlot cattle. J. Am. Vet. Med. Assoc. 169:500-506.
16. Jericho, K.W.F., and L.A. Babiuk. 1983. The effect of dose, route and virulence of bovine herpesvirus-1 vaccine on experimental respiratory disease in cattle. Can. J. Comp. Med. 47:133-139.
17. Kowalski, J., S.A. Gilbert, S. van Drunen Littel-van den Hurk, J. van den Hurk, L.A. Babiuk, and T.J. Zamb. 1993. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11:1100-1108.
18. Mishkin, E.M., J.R. Fahey, Y. Kino, R.J. Klein, A.S. Abramovitz, and S.J. Mento. 1991. Native herpes simplex virus glycoprotein D vaccine: Immunogenicity and protection in animal models. Vaccine 9:147-153.
19. Mitchell, A. 1974. An outbreak of abortion in a dairy herd following inoculation with an intramuscular infectious bovine rhinotracheitis vaccine. Can. Vet. J. 15:148-150.
20. Nettleton, P.F., and J.M. Sharp. 1980. Infectious bovine rhinotracheitis virus excretion after vaccination. Vet. Rec. 107:379.
21. Oth, D., G. Mercier, P. Perrin, M.L. Joffret, P. Sureau, and L. Thibodeau. 1987. The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2. Cell Immunol. 108:220-226.
22. Parks, G.D., and R.A. Lamb. 1990. Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein. Virology 178:498-508.
23. Pastoret, P.P., L.A. Babiuk, V. Misra, and P. Griebel. 1980. Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis and dexamethasone. Infect. Immun. 29:483-488.
24. Salk, J., P.A. Bretscher, P.L. Salk, M. Clerici, and G.M. Shearer. 1992. A strategy for prophylactic vaccination against HIV. Science 260:1270-1272.
25. Thiry, E., B. Brouchier, J. Saliki, M. Pirak, and P.P. Pastoret. 1985. Excretion and reexcretion of thermosensitive and wild-type strains of infectious bovine rhinotracheitis virus after co-infection or two successive infections. Vet. Microbiol. 10:371-380.
26. Tikoo, S.K., M.D. Parker, J.V. van den Hurk, J. Kowalski, T.J. Zamb, and L.A. Babiuk. 1993. Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV J. Virol. 67:726-733.
27. Tikoo, S.K., T.J. Zamb, and L.A. Babiuk. 1993. Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 67:2103-2109.
28. Van Drunen Littel-van den Hurk, S., G.A. Gifford, and L.A. Babiuk. 1990. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8:358-368.
29. Van Drunen Littel-van den Hurk, S., M.D. Parker, B. Massie, J.V. van den Hurk, R. Harland, L.A. Babiuk, and T.J. Zamb. 1993. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11:25-35.
30. Van Drunen Littel-van den Hurk, S., J. Van Donkersgoed, J. Kowalski, J.V. van den Hurk, R. Harland, L.A. Babiuk, and T.J. Zamb. 1994. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12:1295-1302.
31. Yang, X., R.S. Gieni, T.R. Mosmann, and K.T. HayGlass. 1993. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 178:349-353.
32. Yates, W.D.G. 1982. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46:225-263.